We have illustrated that ILT4 in EGFR-activated tumor cells impeded T cell immunity indirectly through the accumulation of M2-like TAMs and directly by inhibiting T cell survival and cytotoxicity, which might be the main causes of ICI resistance. The gene discussed is EGFR; the disease is neoplasm.